The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The global Oncolytic Virus Therapy market was valued at US$ 6 million in 2023 and is anticipated to reach US$ 29 million by 2030, witnessing a CAGR of 24.9% during the forecast period 2024-2030.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
Report Scope
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Amgen
- Oncolytics Biotech
- Viralytics
- Transgene SA
- Oncolys BioPharma
- Targovax
- PsiOxus Therapeutics
- SillaJen Biotherapeutics
- Sorrento Therapeutics
- Lokon Pharma
- Genelux Corporation
- Vyriad
- TILT Biotherapeutics
- Cold Genesys
Segment by Type
- HSV-based Oncolytic Viruses
- Adenoviruses-based Oncolytic Viruses
- Vaccinia Virus-based Oncolytic Viruses
- Vesicular Stomatitis Virus-based Oncolytic Viruses
- Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
- Melanoma
- Prostate Cancer
- Breast Cancer
- Ovarian Cancer
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HSV-based Oncolytic Viruses
1.2.3 Adenoviruses-based Oncolytic Viruses
1.2.4 Vaccinia Virus-based Oncolytic Viruses
1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Therapy Market Perspective (2019-2030)
2.2 Oncolytic Virus Therapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Therapy Market Dynamics
2.3.1 Oncolytic Virus Therapy Industry Trends
2.3.2 Oncolytic Virus Therapy Market Drivers
2.3.3 Oncolytic Virus Therapy Market Challenges
2.3.4 Oncolytic Virus Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Therapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2023
3.5 Oncolytic Virus Therapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Therapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Therapy Breakdown Data by Type
4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Therapy Breakdown Data by Application
5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Therapy Market Size (2019-2030)
6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Therapy Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size (2019-2030)
7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Therapy Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Therapy Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Therapy Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Therapy Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Therapy Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2019-2024)
11.14.5 Cold Genesys Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
